Molecular Docking Studies of Indolyl-Benzodioxyl-Chalcone, Pyrrolyl-Benzodioxyl- Chalcone, and Thiophenyl-Benzodioxyl-Chalcone as an Antimalarial Agent

Abstract:

The drug resistance condition of P. falciparum pose a major challenge in the fight against malaria. This prompts a comprehensive research in an effort to discover new drug candidates. Therefore, chalcone was modified into 24 new compounds, including indolyl-benzodioxyl-chalcone, pyrrolyl-benzodioxyl-chalcone, and thiophenyl-benzodioxyl-chalcone in the course of this study. Moreover, these compounds are commercial malaria mediciations screened for their inhibitory activity using molecular docking simulations. Subsequent results of combined indolyl-benzodioxyl-chalcone and PfDHFR-TS showed the intrinsic indolyl components produced stronger interactions referenced to pyrrolyl-benzodioxyl-chalcone, thiophenyl-benzodioxyl-chalcone, and chloroguanide. Under these circumstances, intense PfDHFR-TS-indolyl-benzodioxyl-chalcone complex was produced with lower binding affinity values (-7.32 to -8.43 kcal/mole) referenced to PfDHFR-TS-pyrrolyl-benzodioxyl-chalcone (-6.38 to -6.68 kcal/mole), PfDHFR-TS-Thiophenyl-benzodioxyl-chalcone (-6.47 to -6.52 kcal/mole), and PfDHFR-TS-chloroguanide (-6.75 kcal/mole). Furthermore, the hydrogen bond interactions developed by indolyl-benzodioxyl-chalcone (7-10) are observably similar to standard chloroguanide compounds and WR99210. These compounds also possess a binding affinity similar to WR99210 (native ligand) and are expected to be potentially anti-malarial candidates.

• Periodical: Key Engineering Materials (Volume 874)
• Pages: 136-142
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.874.136
• Online since: January 2021
• Authors: Kamilia Mustikasari*, Joshua Eka Harap, Tanto Budi Susilo, Noer Komari
• Keywords: Antimalarial, Indolyl-Benzodioxyl-Chalcone, Molecular Docking Study, PfDHFR-TS, Pyrrolyl-Benzodioxyl-Chalcone, Thiophenyl-Benzodioxyl-Chalcone

References

[1] A. Zohra, S. Anwar, A. Fitri, M. Nasution, Klasifikasi Wilayah Provinsi Aceh Berdasarkan Tingkat Kerentanan Kasus Malaria Tahun 2015 – 2018, Jurnal Kesehatan Lingkungan Indonesia. 18 (2019) 25-33.

DOI: 10.14710/jkli.18.1.25-33

[2] Ministry of Health, Pedoman Manajemen Malaria (2014).

[3] Pan American Health Organization / World Health Organization. Epidemiological Alert: Increase in cases of malaria. Washington, D.C (2017).

[4] Surabhi, B. K. Singh, Computer-Aided Drug Design: An Overview, Journal of Drug Delivery & Therapeutics, 8 (2018) 504-509.

DOI: 10.22270/jddt.v8i5.1894

[5] M. A. F. Nasution, B. Ardiansah, U. S. F. Tambunan, Chalcone and Its Pyrazole Derivatives as Potential Plasmodium falciparum Lactate Dehydrogenase Inhibitor: In Silico Approach for New Antimalarial Drug, The 1st Asian Researcher Symposium. (2016).

[6] A. Hameed,·S. Masood, A. Hameed,· E.Ahmed, A. Sharif, M. I. Abdullah, Anti-malarial, cytotoxicity and molecular docking studies of quinolinyl chalcones as potential anti-malarial agent, Journal of Computer-Aided Molecular Design. 33 (2019) 677-688.

DOI: 10.1007/s10822-019-00210-2

[7] J. Syahri, E. Yuanita, B. A Nurrohmah, R. Armunanto, B. Purwono, Chalcone analogue as potent anti-malarial compounds against Plasmodium falciparum: Synthesis, biological evaluation, and docking simulation study, Asian Pacific Journal of Tropical Biomedicine. 7 (2017) 675-680.

DOI: 10.1016/j.apjtb.2017.07.004

[8] J. Syahri, K. Rullah, R. Armunanto, E. Yuanita, B. A. Nurrohmah, M. F. F. M. Aluwi, L. K. Wai, B. Puwono, Synthesis, biologi evaluation, QSAR analysis, and molecular docking of chalcone derivatives for antimalarial activity, Asian Pacific Journal of Tropical Disease. 7 (2017) 8-13.

DOI: 10.1016/j.apjtb.2017.07.004

[9] M.E. De Oliveira, G. Cenzi, R.R. Nunes, C. R. Andrighetti, D.M. De Sousa Valadão, C., Dos Reis, C. M. O. Simões, R. J. Nunes, M. C. Júnior, A. G. Taranto, B. A. M. Sanchez, G. H. R. Viana, F. De Pilla Varotti, Antimalarial Activity of 4-Metoxychalcones: Docking Studies as Falcipain/Plasmepsin Inhibitors, ADMET and Lipophilic Efficiency Analysis to Identify a Putative Oral Lead Candidate, Molecules. 18 (2013) 15276-15287.

DOI: 10.3390/molecules181215276

[10] R. Pingaew , A. Saekee, P. Mandi, C. Nantasenamat, S. Prachayasittikul, S. Ruchirawat, V. Prachayasittikul, Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents, Eur J Med Chem. 6 (2014) 65-76.

DOI: 10.1016/j.ejmech.2014.07.087

[11] M. Thillainayagam, L. Pandian, K. K. Murugan, V. Vijayaparthasarathi, S. Sundaramoorthy, A. Anbarasu, S. Ramaiah, In silico analysis reveals the anti-malarial potential of quinolinyl chalcone derivatives, Journal of Biomolecular Structure and Dynamics. 33 (2015) 961-977.

DOI: 10.1080/07391102.2014.920277

[12] M. Thillainayagam, K. Malathi, S. Ramaiah, In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase, Journal of Biomolecular Structure and Dynamics. 36 (2018) 3993-4009.

DOI: 10.1080/07391102.2017.1404935

[13] W. Humphrey, A. Dalke, Schulten, K., VMD - Visual Molecular Dynamics,, J. Molec. Graphics. 14 (1996) 33-38.

DOI: 10.1016/0263-7855(96)00018-5

[14] W. L. DeLano, Pymol: An open-source molecular graphics tool. CCP4 Newsletter On Protein Crystallography. 40 (2002)  82-92.

[15] ChemAxon, Marvin 18.28.0, 2018 , (http://www.chemaxon.com).

[16] G. M. Morris, R. Huey, W. Lindstrom, M. F. Sanner, R. K. Belew, D. S. Goodsell, A. J. Olson, Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity, J. Computational Chemistry. 16 (2009) 2785-91.

DOI: 10.1002/jcc.21256

[17] BIOVIA, D. S.. Discovery studio modeling environment. San Diego, Dassault Systemes, Release, 19.0 (2019).

[18] D. Simamora, L. E. Fitri, Antimalarial Drug Resistance: Mechanism and The Role of Drug Combination in Preventing It, Jurnal Kedokteran Brawijaya. XXIII (2007) 82-89.